News | September 27, 2024
Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
The company will also share results in two additional posters for deuruxolitinib
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Pfizer's decision is based on the totality of clinical data
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
This approval reflects company’s unwavering commitment that the quality assurance
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Subscribe To Our Newsletter & Stay Updated
